INS and Hyperglycemia: Moreover, in obese ob/ob mice, C646 treatment through intraperitoneal injection (30 nmol/g/day) for 10 days significantly improved insulin sensitivity and hyperglycemia without significant changes in body weight (Fig. 6, F and G).